81 related articles for article (PubMed ID: 20078964)
1. [Differential expression of microRNAs associated with estrogen receptor alpha and progesterone receptor in typeIand typeII endometrial adenocarcinomas.].
Zhou J; Shen K; Zeng JF; Yang JX; Cao DY; Cui QC
Zhonghua Fu Chan Ke Za Zhi; 2009 Oct; 44(10):765-70. PubMed ID: 20078964
[TBL] [Abstract][Full Text] [Related]
2. microRNA regulation of the expression of the estrogen receptor in endometrial cancer.
Zhou J; Song T; Gong S; Zhong M; Su G
Mol Med Rep; 2010; 3(3):387-92. PubMed ID: 21472251
[TBL] [Abstract][Full Text] [Related]
3. Culture characters, genetic background, estrogen/progesterone receptor expression, and tumorigenic activities of frequently used sixteen endometrial cancer cell lines.
Qu W; Zhao Y; Wang X; Qi Y; Zhou C; Hua Y; Hou J; Jiang SW
Clin Chim Acta; 2019 Feb; 489():225-232. PubMed ID: 30107158
[TBL] [Abstract][Full Text] [Related]
4. Kruppel-like factor 9 is a negative regulator of ligand-dependent estrogen receptor alpha signaling in Ishikawa endometrial adenocarcinoma cells.
Velarde MC; Zeng Z; McQuown JR; Simmen FA; Simmen RC
Mol Endocrinol; 2007 Dec; 21(12):2988-3001. PubMed ID: 17717078
[TBL] [Abstract][Full Text] [Related]
5. Verification of microRNA expression in human endometrial adenocarcinoma.
Jurcevic S; Klinga-Levan K; Olsson B; Ejeskär K
BMC Cancer; 2016 Apr; 16():261. PubMed ID: 27039384
[TBL] [Abstract][Full Text] [Related]
6. Progestin treatment decreases CD133+ cancer stem cell populations in endometrial cancer.
Guy MS; Qamar L; Behbakht K; Post MD; Sheeder J; Sartorius CA; Spillman MA
Gynecol Oncol; 2016 Mar; 140(3):518-26. PubMed ID: 26731726
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells.
Bhat KP; Pezzuto JM
Cancer Res; 2001 Aug; 61(16):6137-44. PubMed ID: 11507064
[TBL] [Abstract][Full Text] [Related]
8. Hsa-microRNA-181a is a regulator of a number of cancer genes and a biomarker for endometrial carcinoma in patients: a bioinformatic and clinical study and the therapeutic implication.
He S; Zeng S; Zhou ZW; He ZX; Zhou SF
Drug Des Devel Ther; 2015; 9():1103-75. PubMed ID: 25733820
[TBL] [Abstract][Full Text] [Related]
9. miR-196a overexpression activates the MEK/ERK signal and represses the progesterone receptor and decidualization in eutopic endometrium from women with endometriosis.
Zhou M; Fu J; Xiao L; Yang S; Song Y; Zhang X; Feng X; Sun H; Xu W; Huang W
Hum Reprod; 2016 Nov; 31(11):2598-2608. PubMed ID: 27619769
[TBL] [Abstract][Full Text] [Related]
10. SLUG/HIF1-α/miR-221 regulatory circuit in endometrial cancer.
Penolazzi L; Bonaccorsi G; Gafà R; Ravaioli N; Gabriele D; Bosi C; Lanza G; Greco P; Piva R
Gene; 2019 Aug; 711():143938. PubMed ID: 31220580
[TBL] [Abstract][Full Text] [Related]
11. Selective down-regulation of progesterone receptor isoform B in poorly differentiated human endometrial cancer cells: implications for unopposed estrogen action.
Kumar NS; Richer J; Owen G; Litman E; Horwitz KB; Leslie KK
Cancer Res; 1998 May; 58(9):1860-5. PubMed ID: 9581825
[TBL] [Abstract][Full Text] [Related]
12. Endometrial miR-181a and miR-98 expression is altered during transition from normal into cancerous state and target PGR, PGRMC1, CYP19A1, DDX3X, and TIMP3.
Panda H; Chuang TD; Luo X; Chegini N
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1316-26. PubMed ID: 22492871
[TBL] [Abstract][Full Text] [Related]
13. miR-205 inhibits cell growth by targeting AKT-mTOR signaling in progesterone-resistant endometrial cancer Ishikawa cells.
Zhuo Z; Yu H
Oncotarget; 2017 Apr; 8(17):28042-28051. PubMed ID: 28427207
[TBL] [Abstract][Full Text] [Related]
14. [Functional study of progesterone receptor isoforms in endometrial cancer cell lines].
Lu Y; Liao QP; Chen CL; Yu L
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):475-9. PubMed ID: 17068617
[TBL] [Abstract][Full Text] [Related]
15. Effects of female sex hormones on clusterin expression and paclitaxel resistance in endometrial cancer cell lines.
Won YS; Lee SJ; Yeo SG; Park DC
Int J Med Sci; 2012; 9(1):86-92. PubMed ID: 22211095
[TBL] [Abstract][Full Text] [Related]
16. [Preliminary investigation of the expression and functions of insulin receptor isoforms in endometrial carcinoma].
Zhang G; Li XP; Wang JL; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):839-45. PubMed ID: 23302125
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
[TBL] [Abstract][Full Text] [Related]
18. Expression analysis of estrogen-metabolizing enzymes in human endometrial cancer.
Smuc T; Rupreht R; Sinkovec J; Adamski J; Rizner TL
Mol Cell Endocrinol; 2006 Mar; 248(1-2):114-7. PubMed ID: 16337331
[TBL] [Abstract][Full Text] [Related]
19. Progesterone induces progesterone receptor gene (PGR) expression via rapid activation of protein kinase pathways required for cooperative estrogen receptor alpha (ER) and progesterone receptor (PR) genomic action at ER/PR target genes.
Diep CH; Ahrendt H; Lange CA
Steroids; 2016 Oct; 114():48-58. PubMed ID: 27641443
[TBL] [Abstract][Full Text] [Related]
20. Progesterone-Induced miR-152 Inhibits the Proliferation of Endometrial Epithelial Cells by Downregulating WNT-1.
Nie L; Zhao YB; Pan JL; Lei Y; Liu M; Long Y; Zhang JH; Hu Y; Xu MQ; Yuan DZ; Yue LM
Reprod Sci; 2017 Oct; 24(10):1444-1453. PubMed ID: 28122483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
